bpc-157 status fda 2026 advisory committee votes to add popular peptide to drug compounding list FDA reviews BPC-157, TB-500 and
FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them FDA panel votes to place popular peptide BPC 157 on compounding list Reuters BPC 157 FDA Status 2026: What the RFK Reclassification Means for Patients AgeMD
Pay in 4 interest-free payments of $5.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25

